09th November 2021 | Pharma Updates
India To Purchase 1 Cr Zydus Cadila Covid Vaccine At Rs 265 Each
It is the first vaccine cleared by India’s drug regulator for aged above 12 yrs of age.
Wockhardt Collaborates With Russian Direct Investment Fund For Production & Supply Of Sputnik-V, Sputnik Light
The agreement has been laid out by Russia’s Covid vaccine partner ENSO Healthcare.
BGD completes 99% stake acquisition of Balaxi Healthcare
Balaxi Healthcare El Salvador has become the step-down subsidiary of Balaxi Pharma. Total cost of acquistion is USD 2000.
Sun Pharma'ssubsidiaries to pay USD 85 mn in settlement pacts over antitrust litigation
Taro Pharma and Sun Pharmaceutical Industries, Inc. have signed agreements with the Direct Purchaser Plaintiffs in the In re Generic Pharmaceuticals Pricing Antitrust Litigation.
Meiji Seika Pharma to construct facility in India
The Japan-based pharma company has decided to build a new manufacturing unit at Adcock Ingram in Bengaluru, India.
Pharma industry study will help to boost competition, says CCI Chief
Competition Commission of India Chief Ashok Kumar Gupta added that it will help us to identify steps for drug affordability.
Kosoderma opens its 7th clinic at RMV Extension, Bengaluru
We offer a variety of non-invasive solutions,
says Dr Shalini Krishnamurthy, Head
Cosmetic Dermatologist, Kosoderma’s RMV